An international delphi survey and consensus meeting to define the risk factors for ureteral stricture after endoscopic treatment for urolithiasis.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
13 Jul 2024
Historique:
received: 18 03 2024
accepted: 01 06 2024
medline: 14 7 2024
pubmed: 14 7 2024
entrez: 13 7 2024
Statut: epublish

Résumé

Iatrogenic ureteral strictures (US) after endoscopic treatment for urolithiasis represent a significant healthcare concern. However, high-quality evidence on the risk factors associated with US is currently lacking. We aimed to develop a consensus statement addressing the definition, risk factors, and follow-up management of iatrogenic US after endoscopic treatment for urolithiasis. Utilizing a modified Delphi method, a steering committee developed survey statements based on a systematic literature review. Then, a two-round online survey was submitted to 25 experts, offering voting options to assess agreement levels. A consensus panel meeting was held for unresolved statements. The predetermined consensus threshold was set at 70%. The steering committee formulated 73 statements. In the initial survey, consensus was reached on 56 (77%) statements. Following in-depth discussions and refinement of 17 (23%) statements in a consensus meeting, the second survey achieved consensus on 63 (86%) statements. This process underscored agreement on pivotal factors influencing US in endoscopic urolithiasis treatments. This study provides a comprehensive list of categorized risk factors for US following endoscopic urolithiasis treatments. The objectives include enhancing uniformity in research, minimizing redundancy in outcome assessments, and effectively addressing risk factors associated with US. These findings are crucial for designing future clinical trials and guiding endoscopic surgeons in mitigating the risk of US.

Identifiants

pubmed: 39002090
doi: 10.1007/s00345-024-05103-0
pii: 10.1007/s00345-024-05103-0
doi:

Types de publication

Journal Article Consensus Development Conference

Langues

eng

Sous-ensembles de citation

IM

Pagination

412

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

EAU Guidelines Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6
Tonyali S, Yilmaz M, Tzelves L et al (2023) Predictors of Ureteral strictures after Retrograde Ureteroscopic treatment of impacted Ureteral stones: a systematic literature review. J Clin Med 12:3603. https://doi.org/10.3390/jcm12103603
doi: 10.3390/jcm12103603 pubmed: 37240709 pmcid: 10218913
Moretto S, Saita A, Scoffone CM et al (2024) Ureteral stricture rate after endoscopic treatments for urolithiasis and related risk factors: systematic review and meta-analysis. World J Urol 42:234. https://doi.org/10.1007/s00345-024-04933-2
doi: 10.1007/s00345-024-04933-2 pubmed: 38613692
Hasson F, Keeney S, McKenna H (2000) Research guidelines for the Delphi survey technique. J Adv Nurs 32:1008–1015
doi: 10.1046/j.1365-2648.2000.t01-1-01567.x pubmed: 11095242
Witjes JA, Babjuk M, Bellmunt J et al (2020) EAU-ESMO Consensus statements on the management of advanced and variant bladder Cancer-An International Collaborative Multistakeholder Effort†: under the auspices of the EAU-ESMO guidelines committees. Eur Urol 77:223–250. https://doi.org/10.1016/j.eururo.2019.09.035
doi: 10.1016/j.eururo.2019.09.035 pubmed: 31753752
Teoh JY-C, MacLennan S, Chan VW-S et al (2020) An International Collaborative Consensus Statement on En Bloc resection of bladder tumour incorporating two systematic reviews, a two-round Delphi Survey, and a Consensus Meeting. Eur Urol 78:546–569. https://doi.org/10.1016/j.eururo.2020.04.059
doi: 10.1016/j.eururo.2020.04.059 pubmed: 32389447
Sunaryo PL, May PC, Holt SK et al (2022) Ureteral strictures following ureteroscopy for kidney Stone Disease: a Population-based Assessment. J Urol 208:1268–1275. https://doi.org/10.1097/JU.0000000000002929
doi: 10.1097/JU.0000000000002929 pubmed: 35984646
Prattley S, Voss J, Cheung S et al (2018) Ureteroscopy and stone treatment in the elderly (≥ 70 years): prospective outcomes over 5- years with a review of literature. Int Braz J Urol off J Braz Soc Urol 44:750–757. https://doi.org/10.1590/S1677-5538.IBJU.2017.0516
doi: 10.1590/S1677-5538.IBJU.2017.0516
Emiliani E, Piccirilli A, Cepeda-Delgado M et al (2021) Flexible ureteroscopy in extreme elderly patients (80 years of age and older) is feasible and safe. World J Urol 39:2703–2708. https://doi.org/10.1007/s00345-020-03448-w
doi: 10.1007/s00345-020-03448-w pubmed: 32960326
Tonyali S, Pietropaolo A, Emiliani E et al (2023) Factors associated with ureteral strictures following ureteroscopy for impacted ureteral stones? A multicenter study by EAU-YAU endourology and urolithiasis working party. Actas Urol Esp S 2173–5786(23):00045–00048. https://doi.org/10.1016/j.acuroe.2023.04.005
doi: 10.1016/j.acuroe.2023.04.005
Al-Nabulsi Z, Phan YC, Abdalla O et al (2021) Surgical and radiological predictive factors for ureteric stricture formation in patients treated with ureteroscopy for ureteric stones. Scand J Urol 55:394–398. https://doi.org/10.1080/21681805.2021.1953581
doi: 10.1080/21681805.2021.1953581 pubmed: 34355993
Fam XI, Singam P, Ho CCK et al (2015) Ureteral stricture formation after ureteroscope treatment of impacted calculi: a prospective study. Korean J Urol 56:63. https://doi.org/10.4111/kju.2015.56.1.63
doi: 10.4111/kju.2015.56.1.63 pubmed: 25598938 pmcid: 4294857
Perez Castro E, Osther PJS, Jinga V et al (2014) Differences in ureteroscopic stone treatment and outcomes for distal, mid-, proximal, or multiple ureteral locations: the Clinical Research Office of the Endourological Society ureteroscopy global study. Eur Urol 66:102–109. https://doi.org/10.1016/j.eururo.2014.01.011
doi: 10.1016/j.eururo.2014.01.011 pubmed: 24507782
Ulvik Ø, Harneshaug J-R, Gjengstø P (2021) Ureteral strictures following Ureteroscopic Stone Treatment. J Endourol 35:985–990. https://doi.org/10.1089/end.2020.0421
doi: 10.1089/end.2020.0421 pubmed: 32962439
Darwish A, Gadelmoula M, Abdelkawi I et al (2019) Ureteral stricture after ureteroscopy for stones: a prospective study for the incidence and risk factors. Urol Ann 11:276. https://doi.org/10.4103/UA.UA_110_18
doi: 10.4103/UA.UA_110_18 pubmed: 31413506 pmcid: 6676818
El-Abd AS, Suliman MG, Abo Farha MO et al (2014) The development of ureteric strictures after ureteroscopic treatment for ureteric calculi: a long-term study at two academic centres. Arab J Urol 12:168–172. https://doi.org/10.1016/j.aju.2013.11.004
doi: 10.1016/j.aju.2013.11.004 pubmed: 26019943
Kılınç MF, Doluoğlu ÖG, Karakan T et al (2016) The effect of ureteroscope size in the treatment of ureteral stone: 15-year experience of an endoscopist. Turk J Urol 42:64–69. https://doi.org/10.5152/tud.2016.84594
doi: 10.5152/tud.2016.84594 pubmed: 27274889 pmcid: 4857919
Maxwell AD, MacConaghy B, Harper JD et al (2019) Simulation of laser lithotripsy-Induced Heating in the urinary tract. J Endourol 33:113–119. https://doi.org/10.1089/end.2018.0485
doi: 10.1089/end.2018.0485 pubmed: 30585741 pmcid: 6388709
Aldoukhi AH, Hall TL, Ghani KR et al (2018) Caliceal Fluid Temperature during High-Power Holmium laser lithotripsy in an in vivo Porcine Model. J Endourol 32:724–729. https://doi.org/10.1089/end.2018.0395
doi: 10.1089/end.2018.0395 pubmed: 29905092 pmcid: 6096348
Wollin DA, Carlos EC, Tom WR et al (2018) Effect of laser settings and Irrigation Rates on Ureteral Temperature during Holmium laser lithotripsy, an in Vitro Model. J Endourol 32:59–63. https://doi.org/10.1089/end.2017.0658
doi: 10.1089/end.2017.0658 pubmed: 29048226
Hu H, Xu L, Wang S et al (2017) Ureteral stricture formation after removal of proximal ureteral stone: retroperitoneal laparoscopic ureterolithotomy versus ureteroscopy with holmium: YAG laser lithotripsy. PeerJ 5:e3483. https://doi.org/10.7717/peerj.3483
doi: 10.7717/peerj.3483 pubmed: 28674654 pmcid: 5494178
Sierra A, Corrales M, Kolvatzis M et al (2022) Thermal Injury and Laser Efficiency with Holmium YAG and Thulium Fiber Laser—An in Vitro Study. J Endourol 36:1599–1606. https://doi.org/10.1089/end.2022.0216
doi: 10.1089/end.2022.0216 pubmed: 35793107
Panthier F, Kaulanjan K, Traxer O Livret pour l’interne lithiase urinaire (collège Français Des enseignants d’urologie) | CFEU), [en ligne], https://www.urofrance.org/wp-content/uploads/2023/06/Lithiase-urinaire.pdf , consulté en septembre 2023
Ahmad Para S, Saleem Wani M, Hamid A et al (2023) Incidence of ureteric strictures following ureteroscopic laser lithotripsy: Holmium:YAG Versus Thulium Fiber laser. Urol Res Pract 49:198–204. https://doi.org/10.5152/tud.2023.22264
doi: 10.5152/tud.2023.22264 pubmed: 37877870 pmcid: 10346094
Chen S, Zhou L, Wei T et al (2017) Comparison of Holmium: YAG laser and pneumatic lithotripsy in the treatment of Ureteral stones: an Update Meta-Analysis. Urol Int 98:125–133. https://doi.org/10.1159/000448692
doi: 10.1159/000448692 pubmed: 27505176
Traxer O, Thomas A (2013) Prospective evaluation and classification of Ureteral Wall injuries resulting from insertion of a Ureteral Access Sheath during Retrograde Intrarenal surgery. J Urol 189:580–584. https://doi.org/10.1016/j.juro.2012.08.197
doi: 10.1016/j.juro.2012.08.197 pubmed: 22982421
Stern KL, Loftus CJ, Doizi S et al (2019) A Prospective Study Analyzing the Association between High-grade Ureteral Access Sheath injuries and the formation of Ureteral strictures. Urology 128:38–41. https://doi.org/10.1016/j.urology.2019.02.032
doi: 10.1016/j.urology.2019.02.032 pubmed: 30878681
Zeng G, Zhao Z, Mazzon G et al (2022) European Association of Urology Section of Urolithiasis and International Alliance of Urolithiasis Joint Consensus on Retrograde Intrarenal surgery for the management of Renal stones. Eur Urol Focus 8:1461–1468. https://doi.org/10.1016/j.euf.2021.10.011
doi: 10.1016/j.euf.2021.10.011 pubmed: 34836838
Skolarikos A, Gravas S, Laguna MP et al (2011) Training in ureteroscopy: a critical appraisal of the literature. BJU Int 108:798–805 discussion 805. https://doi.org/10.1111/j.1464-410X.2011.10337.x
doi: 10.1111/j.1464-410X.2011.10337.x pubmed: 21884354
Sugihara T, Yasunaga H, Horiguchi H et al (2013) A nomogram predicting severe adverse events after ureteroscopic lithotripsy: 12 372 patients in a Japanese national series. BJU Int 111:459–466. https://doi.org/10.1111/j.1464-410X.2012.11594.x
doi: 10.1111/j.1464-410X.2012.11594.x pubmed: 23253797
Dong H, Peng Y, Li L, Gao X (2018) Prevention strategies for ureteral stricture following ureteroscopic lithotripsy. Asian J Urol 5:94–100. https://doi.org/10.1016/j.ajur.2017.09.002
doi: 10.1016/j.ajur.2017.09.002 pubmed: 29736371
Moher D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1. https://doi.org/10.1186/2046-4053-4-1
doi: 10.1186/2046-4053-4-1 pubmed: 25554246 pmcid: 4320440
Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71
doi: 10.1136/bmj.n71 pubmed: 33782057 pmcid: 8005924

Auteurs

Stefano Moretto (S)

Department of Biomedical Sciences, Humanitas University, Milan, Italy. stefano.moretto.ch@gmail.com.
Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy. stefano.moretto.ch@gmail.com.

A Saita (A)

Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.

C M Scoffone (CM)

Department of Urology, Cottolengo Hospital, Turin, Italy.

M Talso (M)

Department of Urology, Luigi Sacco University Hospital, Milan, Italy.

B K Somani (BK)

Department of Urology, University Hospital Southampton NHS Trust, Southampton, UK.

O Traxer (O)

Department of Urology, Sorbonne Université, Paris, France.

O Angerri (O)

Department of Urology, Fundació Puigvert University Autonoma de Barcelona, Barcelona, Spain.

E Liatsikos (E)

Department of Urology, University Hospital of Patras, Patras, Greece.

Y Ulvik (Y)

Department of Urology, Haukeland University Hospital, Bergen, Norway.

C M Cracco (CM)

Department of Urology, Cottolengo Hospital, Turin, Italy.

E X Keller (EX)

Department of Urology, University Hospital Zurich, Zurich, Switzerland.

A Pietropaolo (A)

Department of Urology, University Hospital Southampton NHS Trust, Southampton, UK.

T Tailly (T)

Department of Urology, University Hospital Ghent, Ghent, Belgium.

M Corrales (M)

Department of Urology, Sorbonne Université, Paris, France.

V De Coninck (V)

Department of Urology, AZ Klina, Brasschaat, Belgium.

U Nagele (U)

Department of Urology, General Hospital Hall in Tirol, Hall in Tirol, Austria.

S Ferretti (S)

Department of Urology, Azienda Ospedaliero-Universitaria di Modena, Baggiovara, Italy.

P Kronenberg (P)

Department of Urology, Hospital CUF Descobertas, Lisbon, Portugal.

L Carmignani (L)

Department of Urology, University of Milan, Milan, Italy.

P J Osther (PJ)

Department of Urology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark.

I K Goumas (IK)

Department of Urology, Istituto Clinico Beato Matteo, Vigevano, Italy.

L Ajayi (L)

Department of Urology, Royal Free London NHS Foundation Trust, London, UK.

P Acquati (P)

Department of Urology, IRCCS Policlinico San Donato, Milan, Italy.

D Perez-Fentes (D)

Department of Urology, University Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain.

T R W Herrmann (TRW)

Department of Urology, Spital Thurgau AG, Frauenfeld, Switzerland.
Hannover Medical School, Hannover, Germany.
Division of Urology, Department of Surgical Sciences, Stellenbosch University, Western Cape, Stellenbosch, South Africa.

N M Buffi (NM)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH